N/A N=657 Clinical Use of a New Neonatal MRI System
Magnetic Resonance Imaging
Primary: Number of Participants With Adverse Events as Observed During and After Scanning. — 4 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=233 A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Schizophrenia
Primary: Change From Baseline to Week 12/End of Treatment (EoT) in Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery…
N/A N=30 Study of Suture Repair of Torn Meniscus in the Knee
Meniscal Tear · Meniscus Tear
Primary: Freedom From Re-operation of the Index Meniscus Repair Site (Incidence of Subjects Requiring Re-operation) — 26; 1; 23; 2 Participants
N/A N=10 Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
Hyperinsulinism · Diabetes · Pancreatic Diseases
Primary: Mean Plasma Glucose Level. — 149.666118; 162.574753 mg/dL
N/A N=80 The Second-Generation MCCG for Upper Gastrointestinal Tract.
Capsule Endoscopy
Primary: Circumferential Visualization of the Z-line — 0; 5; 5; 7 Participants
Phase 2 N=210 Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Bacterial Infections · Infection
Primary: Clinical Response — 54; 48; 47; 6 Participants
Early Phase 1 N=19 CRF - Nociceptin Receptor Interactions
Healthy
Primary: [C-11]NOP-1A Volume of Distribution Expressed Relative to Total Plasma Concentration — 16.3; 18.7; 11.6; 13.3 mL/cm^3 — p=0.005
Phase 2 N=12 PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma · Recurrent Metastatic Squamous Neck Cancer With Occult Primary · Recurrent Salivary Gland Cancer
Primary: Compensatory Signaling/Feedback Loop Signaling Evaluated by Measurement of Phosphorylated (p)-EGFR
N/A N=87 Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Leukemia · Myelodysplastic Syndrome · Multiple Myeloma
Primary: Percentage of Participants With Neutrophil Engraftment — 85.1 percentage of patients
Phase 2 N=105 A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Renal Cell Carcinoma
Primary: Biomarkers in Blood and Archived Tissue Samples, and Their Correlation With Clinical Activity in Subjects With Advanced Renal Cell Cancer Treated With Tivozanib.
N/A N=600 Clinical Staging Tools for the Impacts of Obesity on Individuals
Morbid Obesity
Primary: Changes in Obesity Scores After Weight Loss Treatment — 600 Participants
Phase 4 N=29 Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
Renal Transplantation
Primary: Renal Allograft Function — 1.34; 1.38 mg/dL — p=<0.05
Phase 3 N=1,202 A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Primary: Progression Free Survival (PFS), as Determined by the Investigator in Arm B Versus Arm C in the Teff-high WT Population and ITT-WT Population — 11.3; 6.8; 8.3; 6.8…
N/A N=40 Feasibility Study of a Belt Applicator
Body Fat Disorder
Primary: Change in the Fat Layer of the Treated Area as Measured by Ultrasound The Change in Fat Layer Thickness in the Treated Outer Thigh — -0.25 cm
Phase 3 N=255 Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Persistent Pregnancy of Unknown Location · Ectopic Pregnancy
Primary: Number of Participants With Uneventful Clinical Resolution of a Pregnancy of Unknown Location Without Change From the Initial Management Strategy — 31; 42; 45 Participants